MAR 06, 2018 10:00 PM PST

Increasing Endogenous Cannabinoid Levels May Reduce Neuropathic Orofacial Pain

WRITTEN BY: Mauri Brueggeman

Neurotransmitter systems in the body have incredible functionality and versatility.  One such system is the Endocannabinoid System (ES).  Studies have begun examining the complex interaction of this system in the body and within numerous physiological processes. Recent research has shown the usefulness of cannabis compounds, specifically cannabinoids, in the treatment of neuropathic pain through ES complex signalling mechanisms.  Many have focused their attention solely on phytocannabinoids found in the cannabis plant or endocannabinoids found in the human body.  Still others have explored the pathophysiological process to better understand neuropathic pain.

The process of feeling or sensing pain involves the endocannabinoid system and researchers have found cannabis and phytocannabinoids can reduce neuropathic pain symptoms.  Some groups have chosen to evaluate options for reducing pain in specific types of neuropathies.  One area of active research is in neuropathic orofacial pain (NOP). 

There are a multitude of causes for NOP and the underlying physiological process of why that pain occurs is mostly unknown so identifying therapeutic options is challenging.  Researchers in Europe began looking that this years ago but a new article in Journal of Oral Science’s March 2018 publication provides new insights into the possibilities of pain management for orofacial pain.

The group began examining how endocannabinoids (produced in the body) affect pain receptors and designed an animal study to manipulate endocannabinoids in vivo and evaluate their perceived effects on NOP.  Kamimura, et al., (J Oral Sci) postulated that the endocannabinoid 2-arachydonoylglycerol (2-AG) present in the brain could reduce the pain signals generated by orofacial nerve injury or damage.  2-AG is degraded by enzymes in vivo causing pain signals to chronically persist.  The researchers introduced an inhibition factor, JZL184, which prevents the enzymatic action of monoacylglycerol (MAGL).  MAGL breaks down 2-AG in vivo.

Upon completion of this study, Kamimura, et al. found that by restricting degradation of 2-AG, therefore leaving increased amounts of endogenous 2-AG in the brain, orofacial pain was attenuated.  This mechanism shows promise for future therapeutic treatment options for NOP.  Additional challenges are the differences between animal studies and translation to human trials; however, because the compounds used in the study are endogenous normally, perhaps converting the design for clinical trials may not be quite as challenging. 

 

 

 

Sources: Journal of Oral SciencePain, International Journal of Biochemistry and Cell Biology,

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
SEP 25, 2020
Health & Medicine
Does Cannabis Affect Brain Health in Older People?
SEP 25, 2020
Does Cannabis Affect Brain Health in Older People?
Demographic data shows rising cannabis use among older people, so what is the likely effect on cognitive funct ...
OCT 22, 2020
Cannabis Sciences
Cannabis Reduces OCD Symptoms by 50%
OCT 22, 2020
Cannabis Reduces OCD Symptoms by 50%
Researchers from Washington State University have found that smoking cannabis can lead to a short term reduction in up t ...
OCT 29, 2020
Cannabis Sciences
Hemp 10 Years from Now
OCT 29, 2020
Hemp 10 Years from Now
The hemp industry has experienced major growth in recent years, largely due to legalization in many US states. Today, th ...
NOV 06, 2020
Health & Medicine
Cannabis Help for Fibromyalgia
NOV 06, 2020
Cannabis Help for Fibromyalgia
Fibromyalgia is a debilitating condition with a spectrum of symptoms that include pervasive musculoskeletal pain accompa ...
JAN 09, 2021
Cannabis Sciences
Cannabis Use Does not Increase Risk of Heart Disease
JAN 09, 2021
Cannabis Use Does not Increase Risk of Heart Disease
Previous studies on how cannabis affects cardiovascular health have delivered mixed results. Now, from a study of over 5 ...
FEB 25, 2021
Health & Medicine
Marijuana Legalization Link to Fewer Workers' Compensation Claims
FEB 25, 2021
Marijuana Legalization Link to Fewer Workers' Compensation Claims
A new paper produced partially under the auspices of the federal government and published by the National Bureau of Econ ...
Loading Comments...